Managing patients co-prescribed benzodiazepines and opioids presents significant clinical challenges in primary care. A recent pilot study highlights the value of benzodiazepine tapering support through cognitive-behavioral therapy (CBT). Researchers evaluated whether adding CBT to a standard taper protocol could improve outcomes for patients facing the risks of high-risk medication co-use.

Benefits of Benzodiazepine Tapering Support

The trial compared a CBT-enhanced taper against a standard health education control. Participants rated both interventions as logical and useful. Although treatment engagement remained similar across groups, the results were promising. Approximately 60% of patients in both conditions achieved at least a 50% reduction in their benzodiazepine dose by the two-month follow-up. Consequently, this reduction significantly lowers the risk of adverse drug-related outcomes and overdose.

While the study did not find statistically significant differences between groups for dose reduction, effect sizes favored the CBT group regarding psychological symptoms. Specifically, patients receiving CBT showed better outcomes for anxiety severity and anxiety sensitivity. Therefore, addressing psychological barriers appears crucial during the tapering process. This behavioral adjunct helps patients manage the distress that often triggers a return to higher drug doses.

Practical Application in Primary Care

Implementing behavioral interventions alongside pharmacological tapering addresses the psychological hurdles of medication cessation. Because high anxiety sensitivity often hinders tapering efforts, CBT provides patients with necessary coping mechanisms. Clinicians should consider psychological adjuncts to improve safety in patients using high-risk drug combinations. By integrating these strategies, primary care providers can better manage the dual risks associated with opioid and benzodiazepine co-use.

Frequently Asked Questions

Why is tapering benzodiazepines difficult for patients on opioids?

Patients often experience rebound anxiety and heightened pain sensitivity during withdrawal. The presence of opioids complicates the physiological and psychological response, making a structured support system essential for safety.

How does CBT assist in the tapering process?

CBT helps patients manage anxiety symptoms and catastrophic thinking about pain. This behavioral support makes the dose reduction more tolerable and sustainable over time by providing non-pharmacological coping tools.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Always seek the advice of a qualified healthcare provider regarding any medical condition. Refer to the latest local and national guidelines for clinical practice.

References

• Wolitzky-Taylor K et al. A pilot randomized clinical trial evaluating the feasibility, acceptability, and preliminary efficacy of a cognitive-behavioral therapy adjunct to support benzodiazepine tapering among primary care patients coprescribed benzodiazepines and opioids. Psychol Addict Behav. 2026 Jun 08. doi: 10.1037/adb0001164. PMID: 42258278.


• Centers for Disease Control and Prevention (CDC). Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022.


• National Institute for Health and Care Excellence (NICE). Benzodiazepines and z-drugs: withdrawal. Clinical Knowledge Summaries (CKS).